Stereotactic body radiation therapy using the CyberKnife® system for patients with liver metastases

OncoTargets and Therapy

Volumn 7, Issue , 2014, Pages 915-923

  Yuan, Zhi Yong ^a   Meng, Mao Bin ^a   Liu, Chun Lei ^a   Wang, Huan Huan ^a   Jiang, Chao ^a   Song, Yong Chun ^a   Zhuang, Hong Qing ^a   Yang, Dong ^a   Wang, Jing Sheng ^a   Wei, Wang ^a   Li, Feng Tong ^a   Zhao, Lu Jun ^a   Wang, Ping ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Liver metastasis; Local control; Stereotactic body radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; CYBERKNIFE; ESTHESIONEUROBLASTOMA; FATIGUE; FEMALE; GALLBLADDER CANCER; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; OVARY CANCER; OVERALL SURVIVAL; PANCREAS CANCER; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SARCOMA; STEREOTACTIC BODY RADIATION THERAPY; STOMACH CANCER; TUMOR VOLUME; UTERUS CANCER; VERY ELDERLY; VOMITING;

EID: 84902356175     PISSN: 11786930     EISSN: None     Source Type: Journal    
DOI: 10.2147/OTT.S58409     Document Type: Article

References (30)

1. Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
2. Hess KR, Varadhachary GR, Taylor SH, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106:1624-1633.
3. Poston GJ. Surgical strategies for colorectal liver metastases. Surg Oncol. 2004;13:125-136.
4. Yoon SS, Tanabe KK. Surgical treatment and other regional treatments for colorectal cancer liver metastases. Oncologist. 1999;4: 197-208.
5. Robertson DJ, Stukel TA, Gottlieb DJ, Sutherland JM, Fisher ES. Survival after hepatic resection of colorectal cancer metastases: a national experience. Cancer. 2009;115:752-759.
6. Reddy SK, Barbas AS, Marroquin CE, et al. Resection of non-colorectal non-neuroendocrine liver metastases: a comparative analysis. J Am Coll Surg. 2007;204:372-382.
7. Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol. 2003;14 Suppl 2: 213-216.
8. Albert SR, Horvath WL, Sternfeld WC, et al. Oxaliplatin, fuorouracil, and leucovorin for patients with unresectable liver only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol. 2005;23:9243-9249.
9. Garden OJ, Rees M, Poston GJ, et al. Guidelines for resection of colorectal cancer liver metastases. Gut. 2006;55 Suppl 3:31-38.
10. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for respectability of colorectal liver metastases. Oncologist. 2008;13:51-64.
11. Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol. 2005;23:8490-8499.
12. Lawrence TS, Ten Haken RK, Kessler ML, et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys. 1992;23:781-788.
13. Cheng JC, Wu JK, Huang CM, et al. Radiation induced liver disease after three-dimensional conformal radiotherapy for patients with hepa-tocellular carcinoma: dosimetric analysis and implication. Int J Radiat Oncol Biol Phys. 2002;54:156-162.
14. Katz W, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys. 2007;67:793-798.
15. Mendez Romero A, Wunderink W, Hussain SM, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study. Acta Oncol. 2006;45:831-837.
16. Adler JR Jr, Chang SD, Murphy MJ, Doty J, Geis P, Hancock SL. SBRT: a frameless robotic system for radiosurgery. Stereotact Funct Neurosurg. 1997;69:124-128.
17. Goodman KA, Wiegner EA, Maturen KE, et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys. 2010;78:486-493.
18. Rule W, Timmerman R, Tong L, et al. Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol. 2011;18:1081-1087.
19. Chang DT, Swaminath A, Kozak M, et al. Stereotactic body radiotherapy for colorectal liver metastases. A pooled analysis. Cancer. 2011;117:4060-4069.
20. Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol. 2009;27:1572-1578.
21. Yuan Z, Tian L, Wang P, Song Y, Dong Y, Zhuang H. Comparative research on the effcacy of CyberKnife® and surgical excision for stage I hepatocellular carcinoma. Onco Targets Ther. 2013;6:1527-1532.
22. Tian LJ, Zhuang HQ, Yuan ZY. A comparison between CyberKnife® and neurosurgery in solitary brain metastases from non-small cell lung cancer. Clin Neurol Neurosurg. 2013;115:2009-2014.
23. Wang Q, Song Y, Zhuang H, et al. Robotic stereotactic irradiation and reirradiation for spinal metastases: safety and efficacy assessment. Chin Med J (Engl). 2014;127:232-238.
24. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679-694.
25. Bogaerts J, Ford R, Sargent D, et al; RECIST Working Party. Individual patients data analysis to assess modifcations to the RECIST criteria. Eur J Cancer. 2009;45:248-260.
26. Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE), version 4.0. Available from: http://www. acrin.org/Portals/0/Administration/Regulatory/CTCAE_4.02_2009-09-15_QuickReference_5x7.pdf. Accessed March 31, 2014.
27. Hoyer M, Swaminath A, Bydder S, et al. Radiotherapy for liver metastases: a review of evidence. Int J Radiat Oncol Biol Phys. 2012; 82:1047-1057.
28. Vautravers-Dewas C, Dewas S, Bonodeau F, et al. Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship? Int J Radiat Oncol Biol Phys. 2011;81: e39-e47.
29. Lee MT, Kim JJ, Dinniwell R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol. 2009;27:1585-1591.
30. Stintzing S, Hoffmann RT, Heinemann V, Kufeld M, Rentsch M, Muacevic A. Radiosurgery of liver tumors: value of robotic radiosurgical devise to treat liver tumors. Ann Surg Oncol. 2010;17:2877-2883.